Gelonghui, May 6, 丨 Matilda Biotech (002932.SZ) announced that as of April 30, 2024, the company had repurchased 3,729,593 shares of the company's shares through a dedicated securities account, accounting for 1.60% of the company's total share capital; the highest transaction price of the repurchased shares was 20.98 yuan/share, the minimum transaction price was 19.3 yuan/share, and the total transaction amount was RMB 75,167,465.22 (excluding transaction tax).
明德生物(002932.SZ)：已累计回购1.60%股份
Mingde Biotech (002932.SZ): 1.60% of shares have been repurchased cumulatively
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.